论文部分内容阅读
目的 评价头孢哌酮联用微生态制剂妈咪爱治疗小儿急性菌痢的疗效。方法 选择 1998年 5月～ 2 0 0 0年 5月间住院的急性菌痢患儿共 10 0例 ,随机分成两组 ,治疗组 5 0例 ,对照组 5 0例。两组年龄、性别、入院前腹泻时间及发热时间、临床分型均无显著性差异 (P >0 .0 5 )。治疗组用头孢哌酮静滴 ,同时口服妈咪爱。对照组常规静滴氨苄青霉素及丁胺卡那霉素。结果 治疗组在退热时间、止泻天数、粪常规转阴时间及住院天数方面较对照组明显缩短 ,差异具有显著性 (P <0 .0 1)。结论 头孢哌酮加微生态制剂妈咪爱治疗小儿急性菌痢具有肯定的疗效 ,值得临床推广应用
Objective To evaluate the efficacy of cefoperazone combined with probiotics in the treatment of acute bacillary dysentery in children. Methods A total of 100 children with acute bacillary dysentery who were hospitalized from May 1998 to May 2000 were randomly divided into two groups: 50 in the treatment group and 50 in the control group. There were no significant differences in age, gender, diarrhea time before admission, fever time and clinical classification (P> 0.05). Treatment group with cefoperazone intravenous infusion, while oral Mommy love. Control group routinely ampicillin and amikacin. Results The treatment group was significantly shorter than the control group in the time of antipyretic, the number of days of antidiarrheal, the time of routine negative feces and days of hospitalization, the difference was significant (P <0.01). Conclusion Cefoperazone plus micro-ecological agents Mummy love treatment of children with acute bacillary dysentery have a positive effect, worthy of clinical application